Virulence Mechanisms of Viral Bcl-2 Homologs
Virulence Mechanisms of Viral Bcl-2 Homologs
批准号:
8197123
负责人:
JOHN C REED
金额:
$47.75万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-01 至 2015-11-30
关键词:
AddressAdenovirusesApoptosisApoptoticAutophagocytosisBCL2 geneBindingBiological ModelsCaspase-1CellsCultured CellsDNA VirusesDiseaseEngineeringFamilyFamily memberFoundationsGenesGenomeGoalsHerpesviridaeHomologous GeneHost DefenseHost Defense MechanismImmune responseInflammationInflammatoryInvestigationKnock-in MouseLaboratoriesLearningMediatingMediator of activation proteinMorbidity - disease rateMusMutationNatural ImmunityPathogenicityPlayPoxviridaeProcessProtein FamilyProteinsRoleSiteTestingTherapeuticVaccinia virusViralViral InterferenceViral ProteinsVirulenceVirusVirus Diseasesbasecytokinedefense responsegammaherpesvirushuman diseasein vivoinhibition of autophagyinhibitor/antagonistmembermortalitymutantnovelnovel strategiespathogenpublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): DNA viruses are responsible for extensive morbidity and mortality on a worldwide basis. Viral homologs of anti-apoptotic Bcl-2 family proteins are encoded in the genomes of several classes of DNA viruses. In Vaccinia Virus (VV), a poxvirus-family member that has served as a paradigm for investigations of many aspects of host-pathogen interactions, at least two viral Bcl-2 genes have been identified, F1L and N1L. Neither F1L nor N1L is required for VV infection or replication, but both of these genes make strong contributions to virulence in vivo. Thus, these viral Bcl-2 (vBcl-2) homologs are critically important for in vivo viral pathogenicity of VV. While the anti-apoptotic activity of F1L and N1L is an obvious candidate for explaining their contribution to viral virulence, we have discovered that F1L and N1L have additional functions that include binding to and suppressing the pro-inflammatory actions of NLR-family proteins, important mediators of innate immunity. Viral Bcl-2 proteins are also known to bind Beclin and suppress autophagy, recently recognized as a host defense mechanism against pathogens. We hypothesize the vBcl-2 homologs are multifunctional proteins that utilize 3 discrete mechanisms to thwart host defense mechanisms: (a) suppression of apoptosis; (b) inhibition of autophagy; and (c) interference with NLR-mediated innate immune responses. The hypothesis that we will test is that neutralization by vBcl-2 proteins of each of these 3 classes of host cell targets significantly contributes to virulence. Specifically, we will: (1) Produce site-specific mutations in F1L and N1L that selectively abolish their ability to interact with (a) pro-apoptotic Bcl-2 family proteins [apoptosis]; (b) NLRs [inflammation]; and (c) Beclin [autophagy]; (2) Test the effects of the engineered vBcl-2 proteins on apoptosis, inflammation, and autophagy in cultured cells; (3) Produce recombinant vaccinia viruses with knock-in of F1L and N1L mutants; and (4) Compare the virulence of these recombinant vaccinia viruses in mice. By using VV as a model system, our results will lay a foundation for understanding the role of viral Bcl-2 homologs in viral pathogenicity, thus serving as a paradigm for other DNA viruses that contain vBcl-2 genes and that cause debilitating human diseases. Also, by learning how viruses interfere with apoptosis, autophagy, and inflammation, the information generated may reveal novel strategies for mimicking aspects of vBcl-2 function in therapeutically useful ways for addressing disorders in which excessive apoptosis, autophagy, and inflammation play central roles.
PUBLIC HEALTH RELEVANCE: DNA viruses are responsible for extensive morbidity and mortality on a worldwide basis, and yet few therapeutic options are available to counteract these pathogens. Viral homologs of anti-apoptotic Bcl-2 family proteins are encoded in the genomes of several classes of DNA viruses but their roles and mechanism in viral disease are largely unknown. The hypothesis that we will test is that neutralization by viral Bcl-2 proteins of specific classes of host cell proteins significantly contributes to virulence, which will lay a foundation for developing new strategies for viral therapeutics based on disrupting interactions of viral Bcl-2 proteins with their host cell targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IAP Family Proteins and Cancer
-
批准号:8221594
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:JOHN C REED
-
依托单位:
Molecular Inhibition of Apoptosis Inhibitors
-
批准号:8235333
-
项目类别:
-
资助金额:$47.5万
-
财政年份:2011
-
负责人:JOHN C REED
-
依托单位:
Chemical Inhibitors of Autophagins for Autophagy modulation
-
批准号:8099787
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Innate Immunity and HIV Restriction
-
批准号:8013192
-
项目类别:
-
资助金额:$97.63万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Chemical Inhibitors of Autophagins for Autophagy modulation
-
批准号:7929409
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Virulence Mechanisms of Viral Bcl-2 Homologs
-
批准号:8026437
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:7655951
-
项目类别:
-
资助金额:$42.98万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:8033736
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Chemical Modulation of the Siah-1 Pathway
-
批准号:7694153
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:8212269
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:7759564
-
项目类别:
-
资助金额:$47.27万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:8082738
-
项目类别:
-
资助金额:$86.71万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Small Molecule Antagonists of IAPs Based on Mimicking SMAC
-
批准号:7737128
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Administrative Core
-
批准号:7737129
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Sanford-Burnham Center for Chemical Genomics
-
批准号:8142967
-
项目类别:
-
资助金额:$1675.25万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:8259775
-
项目类别:
-
资助金额:$83.78万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:7455399
-
项目类别:
-
资助金额:$76.0万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:7877961
-
项目类别:
-
资助金额:$75.25万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Burnham Center for Chemical Genomics
-
批准号:7938917
-
项目类别:
-
资助金额:$1680.82万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Burnham Center for Chemical Genomics
-
批准号:7683049
-
项目类别:
-
资助金额:$1617.27万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
海外基金